PlainPharmaWatch

CMS Open Payments · Tool

RedDress USA, Inc. vs Neo Spine USA, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Neo Spine USA, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 2,657, versus 2,360 for the other company. Its single largest recorded recipient represents 41.2% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

RedDress USA, Inc.
HHI 2,360 · top recipient 34.3%
Ranked #677 of 1,838 companies by HHI
Neo Spine USA, Inc.
HHI 2,657 · top recipient 41.2%
Ranked #623 of 1,838 companies by HHI

Payment Overview

Company A

RedDress USA, Inc.

Total Payments
$184.0K
% of Industry
0.0%
Transactions
225
Avg per Transaction
$817.73
Recipients
225
Avg per Recipient
$817.73
Payment Types
3
Top Payment Type
Consulting Fee
Total Payments
$184.5K
% of Industry
0.0%
Transactions
95
Avg per Transaction
$1.9K
Recipients
95
Avg per Recipient
$1.9K
Payment Types
3
Top Payment Type
Food and Beverage

Highlighted values indicate the higher figure for each metric.

Total payments compared

RedDress USA, Inc. vs Neo Spine USA, Inc. - total reported payments in CMS Open Payments PY2024

Neo Spine USA, Inc.$184.5KRedDress USA, Inc.$184.0K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

RedDress USA, Inc.

Consulting Fee $167.0K

90.8%

Food and Beverage $8.9K

4.8%

Travel and Lodging $8.1K

4.4%

Neo Spine USA, Inc.

Food and Beverage $81.8K

44.3%

Consulting Fee $54.6K

29.6%

Travel and Lodging $48.2K

26.1%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

RedDress USA, Inc.

  1. 1

    ROBERT J SNYDER

    $63,152.52 · 14 txns

  2. 2

    ANTHONY J SENAGORE

    $56,272.70 · 15 txns

  3. 3

    BACHIR TAOULI

    $17,875.00 · 6 txns

  4. 4

    NIR HORESH

    $17,700.00 · 9 txns

  5. 5

    ERIC JAY LULLOVE

    $10,053.33 · 15 txns

Neo Spine USA, Inc.

  1. 1

    Vivek A Mehta

    $75,967.42 · 5 txns

  2. 2

    Steven M Spitz

    $49,923.86 · 20 txns

  3. 3

    Joseph D Ciacci Mr

    $24,666.74 · 7 txns

  4. 4

    John D Attenello Mr

    $9,210.70 · 1 txns

  5. 5

    Robert K Eastlack Mr

    $5,002.79 · 4 txns

Summary Comparison

Metric RedDress USA, Inc. Neo Spine USA, Inc.
Total Payments $184.0K $184.5K
% of Industry Total 0.0% 0.0%
Transaction Count 225 95
Avg per Transaction $817.73 $1.9K
Recipient Count 225 95
Avg per Recipient $817.73 $1.9K
Payment Type Count 3 3
Top Payment Type Consulting Fee Food and Beverage

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.